Chia Tai Tianqing Pharmaceutical (Guangzhou)

Chia Tai Tianqing Pharmaceutical (Guangzhou) is a key subsidiary of Sino Biopharmaceutical, one of China's largest and most innovative pharmaceutical conglomerates. Based in Guangzhou, the company serves as a major hub for the group's research, development, and manufacturing, with a specialized focus on liver disease, oncology, and respiratory health. It is recognized for transitioning from a leading generic manufacturer to an innovation-driven biopharmaceutical player, supported by a robust pipeline of small molecules and biologics. The company's portfolio includes blockbuster treatments for hepatitis and various solid tumors, leveraging advanced GMP-certified facilities. As part of the broader CTTQ group, it maintains extensive R&D capabilities and a strong commercial presence across the Asia-Pacific region.